Presentation of OncoSIGNal at the AACR

Organized by:

This year the American Association for Cancers Research (AACR) Annual Meeting took place at the Orange County Convention Center in Orlando, Florida, US from Friday April 14 to Wednesday April 19, 2023.

Posters not to be missed:

Sunday April, 16 | 1:30 PM – 5:00 PM | Poster Section 39, #9

“Signal transduction pathway activity of TGF-β and Hedgehog as possible response predictors to checkpoint inhibition in patients with advanced melanoma; a retrospective cohort study”.

Stefan van Ravensteijn from Radboud University Medical Center, Nijmegen, The Netherlands will present his findings using OncoSIGNal to predict response to immunotherapy in advanced melanoma patients.

Wednesday April, 19 | 09:00 AM – 1:30 PM | Poster Section 18, #23
Abstract | Poster

“Support for targeted therapy selection in triple negative breast cancer patients using aberrant signal transduction pathway activity profiles”.

InnoSIGN presents the use of OncoSIGNal in triple breast cancer patients to identify new targeted treatment options.

Contact us

E-Mail us
Category group 1
  • Select all
Category group 2
  • Select all